SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
EntreMed (ENMD)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
2135 59 0 ENMD
Emcee:  Mark Wise Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2035 Did anyone see Dr Holadays appearance on CNBC today? Did he deliver a good messGene Hooker-2/14/2000
2034 Antiangiogenesis drugs will probably be tested in combination with other modaliStockDoc-2/11/2000
2033 I suspect that these drugs would be used in conjunction with another therapy. Gregory Rasp-2/11/2000
2032 Your final conclusion is correct. Just a note: external radiation therapy, unStockDoc-2/11/2000
2031 What I am trying to work through, conceptually, is this - and I am not a physicIlaine-2/11/2000
2030 Don't count on that because the number of cases where the physical+chemicalStockDoc-2/10/2000
2029 Alternatively the drugs may allow otherwise incurable cancers to become curableGregory Rasp-2/10/2000
2028 You wrote: "It seems to me that anyone who takes antiangiogenesis drugs foStockDoc-2/10/2000
2027 It seems to me that anyone who takes antiangiogenesis drugs for cancer must do Ilaine-2/9/2000
2026 Obviously ALL efficacious "non-specific" angiogenesis inhibitors willStockDoc-2/9/2000
2025 Just found this - it's old news, but am wondering about the implications foIlaine-2/7/2000
2024 Well some good news on a down day for the stock. Angiostatin approved for PhasGregory Rasp-1/31/2000
2023 Re: ANCHOR POST Through tireless efforts and lot of dedication, a message boarzonkerharris-1/24/2000
2022 what a great post, i just bought a membership so i could respond to this one! newecon-1/24/2000
2021 The field of angiogenesis research is very important. Why is the stock droppingepke-1/24/2000
2020 ANCHOR POST Courtesy of NHLowKIA I HIGHLY recommend that all investors begin rzonkerharris-1/24/2000
2019 ENMD reently flew after a cardiac researcher commented on the possibility of usepke-1/24/2000
2018 How to think of this company Subject: Re: Timeline for ENMD Date: Fri, 21 Januzonkerharris-1/22/2000
2017 Convinced beyond doubt Last Night I posted this on the AOL ENMD board. I am nzonkerharris-1/22/2000
2016 I wonder when the next institutional investor starts buying up these shares. I StockDoc-1/21/2000
2015 Blackmerlin, Does the story re patent suit judgement against Genentech affect ETimeToMakeTheInvs-1/20/2000
2014 Bio-Technology General Wins Patent Suit Against Genentech Genentech Patent Rulblackmerlin-1/19/2000
2013 Have you heard of IMCLONE? There are many substantial companies doing anti-angiepke-1/18/2000
2012 EntreMed (ENMD) Added to The Drug and Biotech Portfolio We are adding EntreMedHans U. Tschanz-1/18/2000
2011 Your reasoning on the cause for scale up could be right. It's certainly notStockDoc-1/17/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News